Jan Brabender
Publications by Year
Research Areas
Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes, Lung Cancer Treatments and Mutations, Esophageal and GI Pathology, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.(2002)
- → ERCC1 and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil Chemotherapy(2001)608 cited
- Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.(2001)
- Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.(2002)
- Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression.(2001)
- → Response Evaluation by Endoscopy, Rebiopsy, and Endoscopic Ultrasound Does Not Accurately Predict Histopathologic Regression After Neoadjuvant Chemoradiation for Esophageal Cancer(2008)153 cited
- → High Expression of HIF1a Is a Predictor of Clinical Outcome in Patients with Pancreatic Ductal Adenocarcinomas and Correlated to PDGFA, VEGF, and bFGF(2008)144 cited
- → Endoscopic therapy for esophageal perforation or anastomotic leak with a self-expandable metallic stent(2009)138 cited
- → Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival(2001)138 cited
- → Prognostic Significance of Cyclooxygenase 2 mRNA Expression in Non-Small Cell Lung Cancer(2002)130 cited